Volume 12, Issue 6, Pages (June 2000)

Slides:



Advertisements
Similar presentations
DNAM-1 Expression Marks an Alternative Program of NK Cell Maturation
Advertisements

Darren M Brown, Erkki Ruoslahti  Cancer Cell 
CD4+CD25+ Immunoregulatory T Cells
Volume 40, Issue 1, Pages (January 2014)
Differentiation of CD4+ T Cells to Th1 Cells Requires MAP Kinase JNK2
Functional divergence of antigen-specific T-lymphocyte responses in syngeneic graft- versus-host disease  Christopher J Thoburn, Yuji Miura, Emilie C Bright,
by Norman Nausch, Ioanna E
Volume 16, Issue 2, Pages (February 2002)
Induction of Somatic Hypermutation Is Associated with Modifications in Immunoglobulin Variable Region Chromatin  Caroline J. Woo, Alberto Martin, Matthew.
Volume 15, Issue 1, Pages (July 2001)
Volume 131, Issue 1, Pages (July 2006)
Durbaka V.R Prasad, Sabrina Richards, Xoi Muoi Mai, Chen Dong  Immunity 
Volume 84, Issue 5, Pages (November 2013)
Volume 13, Issue 3, Pages (September 2000)
Volume 3, Issue 4, Pages (April 2013)
T Cells Redirected to EphA2 for the Immunotherapy of Glioblastoma
Volume 31, Issue 1, Pages (July 2009)
Volume 7, Issue 4, Pages (October 2016)
Volume 26, Issue 4, Pages (April 2018)
Induction of Somatic Hypermutation Is Associated with Modifications in Immunoglobulin Variable Region Chromatin  Caroline J. Woo, Alberto Martin, Matthew.
Volume 34, Issue 1, Pages (January 2011)
Darren M Brown, Erkki Ruoslahti  Cancer Cell 
Down-Regulation of IL-4 Gene Transcription and Control of Th2 Cell Differentiation by a Mechanism Involving NFAT1  Alexander Kiani, João P.B Viola, Andrew.
Volume 21, Issue 9, Pages (November 2017)
T Cell-Produced Transforming Growth Factor-β1 Controls T Cell Tolerance and Regulates Th1- and Th17-Cell Differentiation  Ming O. Li, Yisong Y. Wan, Richard.
Volume 14, Issue 2, Pages (February 2001)
Volume 27, Issue 1, Pages (July 2007)
Volume 13, Issue 6, Pages (December 2000)
Apoptosis Induction by SAHA in Cutaneous T-Cell Lymphoma Cells Is Related to Downregulation of c-FLIP and Enhanced TRAIL Signaling  Nadya Al-Yacoub, Lothar.
Stanford L Peng, Andrea J Gerth, Ann M Ranger, Laurie H Glimcher 
Volume 15, Issue 5, Pages (November 2001)
Volume 11, Issue 19, Pages (October 2001)
NKG2D Blockade Prevents Autoimmune Diabetes in NOD Mice
A Mutation in the Nlrp3 Gene Causing Inflammasome Hyperactivation Potentiates Th17 Cell-Dominant Immune Responses  Guangxun Meng, Fuping Zhang, Ivan Fuss,
Volume 17, Issue 3, Pages (September 2002)
Interleukin-18 and the Costimulatory Molecule B7-1 Have a Synergistic Anti-Tumor Effect on Murine Melanoma; Implication of Combined Immunotherapy for.
Volume 40, Issue 1, Pages (January 2014)
Volume 33, Issue 3, Pages (September 2010)
Abrogation of TGFβ Signaling in T Cells Leads to Spontaneous T Cell Differentiation and Autoimmune Disease  Leonid Gorelik, Richard A Flavell  Immunity 
Role of NF-κB Activity in Apoptotic Response of Keratinocytes Mediated by Interferon-γ, Tumor Necrosis Factor-α, and Tumor-Necrosis-Factor-Related Apoptosis-Inducing.
The IL-6 Trans-Signaling-STAT3 Pathway Mediates ECM and Cellular Proliferation in Fibroblasts from Hypertrophic Scar  Sutapa Ray, Xiaoxi Ju, Hong Sun,
Volume 37, Issue 5, Pages (November 2012)
Volume 39, Issue 5, Pages (November 2013)
Volume 14, Issue 2, Pages (February 2001)
Ly6d-L, a Cell Surface Ligand for Mouse Ly6d
The p73 Gene Is an Anti-Tumoral Target of the RARβ/γ-Selective Retinoid Tazarotene  Marina Papoutsaki, Mauro Lanza, Barbara Marinari, Steven Nisticò, Francesca.
B7h, a Novel Costimulatory Homolog of B7. 1 and B7
Volume 7, Issue 6, Pages (December 1997)
Volume 22, Issue 1, Pages (January 2005)
Volume 7, Issue 2, Pages (August 1997)
Impairment of NK Cell Function by NKG2D Modulation in NOD Mice
Volume 29, Issue 3, Pages (March 2016)
Volume 37, Issue 5, Pages (November 2012)
LAT Links the Pre-BCR to Calcium Signaling
Selective Upregulation of Fibroblast Fas Ligand Expression, and Prolongation of Fas/Fas Ligand-Mediated Skin Allograft Survival, by Retinoic Acid: the.
PUMA, a Novel Proapoptotic Gene, Is Induced by p53
Volume 7, Issue 2, Pages (August 1997)
Thomas M. Schmitt, Juan Carlos Zúñiga-Pflücker  Immunity 
Volume 35, Issue 4, Pages (October 2011)
Volume 4, Issue 6, Pages (June 1996)
Volume 20, Issue 3, Pages (March 2012)
Volume 9, Issue 5, Pages (November 1998)
PU.1 Expression Delineates Heterogeneity in Primary Th2 Cells
Volume 21, Issue 4, Pages (April 2013)
Volume 9, Issue 2, Pages (August 1998)
RORγt, a Novel Isoform of an Orphan Receptor, Negatively Regulates Fas Ligand Expression and IL-2 Production in T Cells  You-Wen He, Michael L Deftos,
Volume 24, Issue 1, Pages (January 2006)
Volume 19, Issue 4, Pages (October 2003)
Volume 28, Issue 4, Pages (April 2008)
Abrogation of TGFβ Signaling in T Cells Leads to Spontaneous T Cell Differentiation and Autoimmune Disease  Leonid Gorelik, Richard A Flavell  Immunity 
Presentation transcript:

Volume 12, Issue 6, Pages 721-727 (June 2000) Retinoic Acid Early Inducible Genes Define a Ligand Family for the Activating NKG2D Receptor in Mice  Adelheid Cerwenka, Alexander B.H Bakker, Terri McClanahan, Janet Wagner, Jun Wu, Joseph H Phillips, Lewis L Lanier  Immunity  Volume 12, Issue 6, Pages 721-727 (June 2000) DOI: 10.1016/S1074-7613(00)80222-8

Figure 1 The mNKG2D-Ig FP Binds to Certain Mouse Tumor Lines but Not to the Pro-B Cell Line Ba/F3 The cell lines LL/2, MLg, CMT, and BA/F3 were stained with the mNKG2D-Ig FP (filled histograms) or the control human IgG (open histograms), followed by a biotinylated anti-human Ig second step and streptavidin-PE. Histograms (x axis, fluorescence, 4 decade log scale; y axis, number of cells) displaying the fluorescence of live cells are presented, and the results are representative of five independent experiments. Immunity 2000 12, 721-727DOI: (10.1016/S1074-7613(00)80222-8)

Figure 2 RAE-1 α, β, γ, δ, and H60 Are Ligands for mNKG2D Ba/F3 were transduced with ecotropic retroviruses encoding RAE-1α, RAE-1β, RAE-1γ, RAE-1δ, and H60. Transduced cells were sorted by flow cytometry for high expression of mNKG2D ligands and stained with mNKG2D-Ig FP (filled histograms) or the control human Ig (open histograms), followed by a biotinylated anti-human Ig and streptavidin-PE. Data displayed are representative of results obtained in three independent experiments. Immunity 2000 12, 721-727DOI: (10.1016/S1074-7613(00)80222-8)

Figure 3 Alignment of RAE-1 α, β, γ, δ Alignment of the predicted amino acid sequences of the RAE-1 α, β, γ, δ polypeptides. Sites where amino acids differ are denoted by an asterisk. Potential sites of N-linked glycosylation are indicated (CHO). “CHO#” designates a potential glycosylation site that is absent in the RAE-1δ isoform. The predicted sites of cleavage of the leader segments, the STP-rich domains, and for the predicted sites for the addition of GPI (caret) are noted. The sequence of RAE-1δ is deposited as GenBank AF257520. Immunity 2000 12, 721-727DOI: (10.1016/S1074-7613(00)80222-8)

Figure 4 Expression Analysis of RAE-1 and H60 The following cell lines (left) were analyzed by RT–PCR (37 cycles at 94°C for 30 s and 68°C for 2 min) for expression of RAE-1 (upper panel) or H60 (middle panel): Lewis lung carcinoma LL/2, lung fibroblast MLg, rectum carcinoma CMT, pro-B cell line Ba/F3, and thymic lymphoma YAC. The following tissues from BALB/c mice (right) were analyzed: brain, spleen, liver, kidney, 7-day-old embryo. The integrity of the cDNA was assessed by PCR by using glyceraldehyde-3-phosphate dehydrogenase primers (lower panel). PCR products of the expected size for RAE-1, H60, and GAPDH are indicated by arrows. A smaller size H60 PCR product has been observed in MLg and at lesser amounts in other cells. Sequencing revealed that this likely represents a splice variant of H60. Immunity 2000 12, 721-727DOI: (10.1016/S1074-7613(00)80222-8)

Figure 5 Retinoic Acid Treatment Induces Expression of the Ligand for mNKG2D on the Embryonic Carcinoma Cell Line F9 (A) F9 cells were mock-treated for 48 hr in the presence of the solvent (ETOH) alone (1:1000 final dilution) (upper panel) or treated with all-trans retinoic acid (1 μM) in ETOH or 20 ng/ml mouse IFN-γ. Cells were then stained with mNKG2D-Ig FP (filled histograms) or the control human Ig (open histograms), followed by a biotinylated anti-human Ig and streptavidin-PE. Histograms displaying the fluorescence of live cells are presented, and the results are representative of three independent experiments. (B) F9 cells were treated with RA as described, and at the indicated time points, cell pellets were snap-frozen. RT–PCR was performed with RAE-1 primers that amplify all four family members and the amount of cDNA was quantified by quantitative PCR (TaqMan) analysis. Data are shown as fold induction over the mock-treated F9 cells. Immunity 2000 12, 721-727DOI: (10.1016/S1074-7613(00)80222-8)

Figure 6 The Ligand for mNKG2D Is a GPI-Linked Cell Surface Protein F9 cells, F9 cells treated with RA for 48 hr, LL/2 cells, and the BW5147 cells transduced with RAE-1γ were mock treated (upper panels) or treated with PI-PLC (lower panels). Subsequently, cells were stained with mNKG2D-Ig FP (filled histograms) or the control human Ig (open histograms), followed by a biotinylated anti-human Ig and streptavidin-PE. Histograms displaying the fluorescence of live cells are presented and the results are representative of three independent experiments. Immunity 2000 12, 721-727DOI: (10.1016/S1074-7613(00)80222-8)

Figure 7 RAE-1- and H60-Transduced Cells Are Preferentially Killed by Mouse NK Cells 4h-51Cr-release assays were performed using IL-2 and IL-15 activated NK cells from B6 mice at the indicated effector to target ratios. (A) The following cell lines were used as targets: Ba/F3 cells (open squares), Ba/F3 cells transduced with RAE-1γ (filled diamonds), and Ba/F3 cells transduced with H60 (filled triangles). (B) Target cells were BW5147 cells (open squares), BW5147 cells transduced with RAE-1γ (filled diamonds), and BW5147 cells transduced with H60 (filled triangles). The data shown are representative for four (A) or two (B) independently performed experiments. Immunity 2000 12, 721-727DOI: (10.1016/S1074-7613(00)80222-8)